Codex Dna Inc. in brief
Codex Dna Inc. is an unlisted company in the Medical Devices industry, based in California, USA. In its latest reported year it had sales of $6 M and a net loss of $18 M.
Written from the figures on this page, so it changes when they do. Dates and sources are under Sources and freshness.
About Codex Dna Inc.
Codex DNA empowers researchers with end-to-end solutions and tools they need to rapidly and securely design, code, and create synthetic DNA. Experience up to 20x increases in productivity to your product development cycles.
Codex Dna Inc. timeline
- 2021
- 🔔· approximateInitial public offering on Nasdaq
Events of Codex Dna Inc. from the company record. Dates marked approximate come from statements without a cited source. Spotted a mistake? Use the correction form below.
More about Codex Dna Inc.
- Acquisitions and changes
- No longer listed: ticker DNAY is not in the SEC's, the US exchanges' or FINRA's lists of traded securities (checked 14 November 2026).
Market cap history
World rank over time
Rank in USA: #3,552 (Jan 2022) · #4,975 (Dec 2022)
Annual results
- Revenue
- $7 M
- Operating income
- —
- Net income
- $-18 M
H-1B hiring at Codex Dna Inc.#
2 labor condition applications certified in fiscal 2022 for 2 positions, at a median wage of $112 K a year.
| Job title | Positions | Median wage offered |
|---|---|---|
| FIELD APPLICATION SCIENTISTMolecular and Cellular Biologists | 1 | $130 K |
| Scientist IMolecular and Cellular Biologists | 1 | $93 K |
Where: San Diego, CA 2
| Fiscal year | Certified | Positions | Median wage | Filed |
|---|---|---|---|---|
| FY2022 | 2 | 2 | $112 K | 2 |
| FY2021 | 2 | 2 | $90 K | 2 |
Source: US Department of Labor, LCA disclosure data. An application is not a visa: USCIS decides each petition later, and the yearly lottery limits new H-1B visas. Filed as Codex DNA, Inc.
How Codex Dna Inc. compares in Medical Devices
- Revenue$7 M · higher than 12% of 155
- Net margin-276.9% · higher than 5% of 144
Peer comparison · Medical Devices
| Company | Market cap | P/E | Net margin | Rev. growth |
|---|---|---|---|---|
| Codex Dna Inc.🇺🇸 | $37 M | — | -276.9% | — |
| Abbott Laboratories🇺🇸 | $181.1 B | 38.5× | 9.8% | +5.7% |
| Medtronic plc🇺🇸 | $121.2 B | 23.2× | 13.9% | +8.4% |
| Stryker Corporation🇺🇸 | $116.5 B | 32.2× | 13.8% | +11.2% |
| Boston Scientific Corporation🇺🇸 | $66.2 B | 18.9× | 16.6% | +19.9% |
| Edwards Lifesciences Corporation🇺🇸 | $52.8 B | 51.7× | 15.3% | +11.6% |
| Shenzhen Mindray Bio-Medical Electronics Co., Ltd.🇨🇳 | $27.8 B | 23.6× | 24.4% | — |
| STERIS plc🇮🇪 | $20.4 B | 24.6× | 13.4% | +8.7% |
| Zimmer Biomet Holdings, Inc.🇺🇸 | $18.2 B | 23.8× | 8.9% | +7.2% |
P/E and margins use trailing 12-month results where available; growth is the latest fiscal year.
Questions, comparisons and similar companies#
Compare head to head
Similar companies by size and industry
- Abbott Laboratories$181.1 B
- Medtronic plc$121.2 B
- Stryker Corporation$116.5 B
- Boston Scientific Corporation$66.2 B
- Edwards Lifesciences Corporation$52.8 B
- Shenzhen Mindray Bio-Medical Electronics Co., Ltd.$27.8 B
Sources and freshness
- Market cap:
- Dec 25, 2022 (last known)
- Profile updated:
- Nov 14, 2026
Figures from value.today research.
How each figure is collected: data sources and methodology. Market caps in US dollars unless you switch the currency.
Work at Codex Dna Inc.? Verify and update this profile — free
Show Codex Dna Inc.'s ranking on your website Get the badge
The badge updates itself as the ranking changes.